LIPOPROTEIN OUTER SURFACE A BORRELIA BURGDORFERI ANTIGEN
UNII TA735GI14L

Substance Identification & Data

This profile provides standardized clinical and technical data for Lipoprotein Outer Surface A Borrelia Burgdorferi Antigen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TA735GI14L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
TA735GI14L
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LIPOPROTEIN OUTER SURFACE A BORRELIA BURGDORFERI ANTIGEN
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lipoprotein Outer Surface A Borrelia Burgdorferi Antigen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LIPOPROTEIN OSPA ANTIGEN RECOMBINANT
LIPOPROTEIN OUTER SURFACE A BORRELIA BURGDORFERI ANTIGEN
LYME DISEASE VACCINE (RECOMBINANT OSPA)

Brand / Trade Names

LYMERIX